1. Home
  2. ATYR vs INTT Comparison

ATYR vs INTT Comparison

Compare ATYR & INTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATYR
  • INTT
  • Stock Information
  • Founded
  • ATYR 2005
  • INTT 1981
  • Country
  • ATYR United States
  • INTT United States
  • Employees
  • ATYR N/A
  • INTT N/A
  • Industry
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • INTT Semiconductors
  • Sector
  • ATYR Health Care
  • INTT Technology
  • Exchange
  • ATYR Nasdaq
  • INTT Nasdaq
  • Market Cap
  • ATYR 105.8M
  • INTT 102.6M
  • IPO Year
  • ATYR 2015
  • INTT 1997
  • Fundamental
  • Price
  • ATYR $0.93
  • INTT $8.03
  • Analyst Decision
  • ATYR Buy
  • INTT Strong Buy
  • Analyst Count
  • ATYR 6
  • INTT 2
  • Target Price
  • ATYR $8.88
  • INTT $12.00
  • AVG Volume (30 Days)
  • ATYR 23.5M
  • INTT 38.1K
  • Earning Date
  • ATYR 11-06-2025
  • INTT 10-31-2025
  • Dividend Yield
  • ATYR N/A
  • INTT N/A
  • EPS Growth
  • ATYR N/A
  • INTT N/A
  • EPS
  • ATYR N/A
  • INTT N/A
  • Revenue
  • ATYR N/A
  • INTT $121,642,000.00
  • Revenue This Year
  • ATYR $420.85
  • INTT N/A
  • Revenue Next Year
  • ATYR $1,919.44
  • INTT $10.38
  • P/E Ratio
  • ATYR N/A
  • INTT N/A
  • Revenue Growth
  • ATYR N/A
  • INTT N/A
  • 52 Week Low
  • ATYR $0.68
  • INTT $5.24
  • 52 Week High
  • ATYR $7.29
  • INTT $9.77
  • Technical
  • Relative Strength Index (RSI)
  • ATYR 27.94
  • INTT 56.63
  • Support Level
  • ATYR $0.68
  • INTT $7.31
  • Resistance Level
  • ATYR $0.86
  • INTT $8.44
  • Average True Range (ATR)
  • ATYR 0.08
  • INTT 0.37
  • MACD
  • ATYR 0.13
  • INTT -0.05
  • Stochastic Oscillator
  • ATYR 69.00
  • INTT 49.32

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About INTT inTest Corporation

inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). The company operates their business and sells its products both domestically and internationally.

Share on Social Networks: